New Vaccine for Virus Threatening Elderly Reduces Hospitalizations by 75%, Study Finds
A new vaccine targeting Respiratory Syncytial Virus (RSV) reduces hospitalizations by 75% among older adults, according to data from clinical trials and recent public health authorizations. The immunization is designed to prevent severe lower respiratory tract infections in adults aged 60 and older, a demographic historically vulnerable to the virus’s complications. Respiratory Syncytial Virus, while … Read more